Dissociating the nicotine and airway sensory effects of smoking

被引:89
作者
Westman, EC
Behm, FM
Rose, JE
机构
[1] VET AFFAIRS MED CTR,NICOTINE RES LAB 151 S,DURHAM,NC 27705
[2] DUKE UNIV,MED CTR,DEPT PSYCHIAT,DURHAM,NC 27705
[3] DUKE UNIV,MED CTR,DIV GEN INTERNAL MED,DURHAM,NC 27705
[4] VET AFFAIRS MED CTR,CTR HLTH SERV RES PRIMARY CARE,DURHAM,NC 27705
关键词
nicotine; smoking; intravenous; infusion;
D O I
10.1016/0091-3057(95)02027-6
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
This study examined the subjective and cardiovascular effects of two of the components of cigarette smoking when given separately: nicotine and airway sensations. Using a within-subjects design, six healthy volunteer smokers, age 18-45 years, who smoked at least 20 cigarettes per day were given six conditions in a randomized, counterbalanced order. The effects of IV nicotine, IV saline, and denicotinized cigarettes were compared to a standard 1-mg cigarette. The standard cigarette produced more of a calming effect and more irritability reduction than either the nicotine or airway sensations alone. The denicotinized cigarette was similar to the standard cigarette condition, except the cigarette condition was associated with higher feelings of ''exhilaration.'' Many of the positive subjective effects from a denicotinized cigarette were comparable to that of a standard cigarette. These data support the hypothesis that replacement of the sensory cues of smoking with ''airway sensory replacement'' may be useful for smoking cessation.
引用
收藏
页码:309 / 315
页数:7
相关论文
共 19 条
[1]   SWITCHING TO ULTRALOW NICOTINE CIGARETTES - EFFECTS OF DIFFERENT TAR YIELDS AND BLOCKING OF OLFACTORY CUES [J].
BALDINGER, B ;
HASENFRATZ, M ;
BATTIG, K .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1995, 50 (02) :233-239
[2]   CLINICAL-EVALUATION OF A CITRIC-ACID INHALER FOR SMOKING CESSATION [J].
BEHM, FM ;
SCHUR, C ;
LEVIN, ED ;
TASHKIN, DP ;
ROSE, JE .
DRUG AND ALCOHOL DEPENDENCE, 1993, 31 (02) :131-138
[3]  
BENOWITZ NL, 1990, J PHARMACOL EXP THER, V254, P1000
[4]   INTRAVENOUS NICOTINE RETARDS TRANSDERMAL ABSORPTION OF NICOTINE - EVIDENCE OF BLOOD-FLOW LIMITED PERCUTANEOUS-ABSORPTION [J].
BENOWITZ, NL ;
JACOB, P ;
OLSSON, P ;
JOHANSSON, CJ .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1992, 52 (03) :223-230
[5]  
BRAUNWALD E, 1984, HEART DISEASE TXB CA, P500
[6]   THE EFFECTIVENESS OF THE NICOTINE PATCH FOR SMOKING CESSATION - A METAANALYSIS [J].
FIORE, MC ;
SMITH, SS ;
JORENBY, DE ;
BAKER, TB .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 271 (24) :1940-1947
[7]  
HEATHERTON TF, 1991, BRIT J ADDICT, V86, P1119
[8]   NICOTINE AS A REINFORCER IN HUMAN-SUBJECTS AND LABORATORY-ANIMALS [J].
HENNINGFIELD, JE ;
GOLDBERG, SR .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1983, 19 (06) :989-992
[9]   CONTROL OF BEHAVIOR BY INTRAVENOUS NICOTINE INJECTIONS IN HUMAN-SUBJECTS [J].
HENNINGFIELD, JE ;
GOLDBERG, SR .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1983, 19 (06) :1021-1026
[10]   CLINICAL-TRIALS USING ASCORBIC-ACID AEROSOL TO AID SMOKING CESSATION [J].
LEVIN, ED ;
BEHM, F ;
CARNAHAN, E ;
LECLAIR, R ;
SHIPLEY, R ;
ROSE, JE .
DRUG AND ALCOHOL DEPENDENCE, 1993, 33 (03) :211-223